AURA (Aura Biosciences) Preferred Dividends: $0.00 Mil (TTM As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AURA Aura Biosciences Inc AURA
35 GF Score
Price $7.81
! 4 Warning Signs
View Full Analysis

What is Aura Biosciences Preferred Dividends?

Aura Biosciences AURA +0.39% 35 Preferred Dividends is $0.00 Mil as of Jun. 2026. GuruFocus rates AURA with a GF Score™ of 35/100. The stock has 4 warning signs investors should review.

Preferred dividend is a dividend that is accrued and paid on a company's preferred shares. Aura Biosciences's preferred dividends for the three months ended in Jun. 2026 was $0.00 Mil. Its preferred dividends for the trailing twelve months (TTM) ended in Jun. 2026 was $0.00 Mil.

Aura Biosciences  (NAS:AURA) Preferred Dividends Explanation

In the event that a company is unable to pay all dividends, claims to preferred dividends take precedence over claims to dividends that are paid on common shares.

Preferred Dividends for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aura Biosciences Preferred Dividends Historical Data

* Premium members only.

The historical data trend for Aura Biosciences's Preferred Dividends can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Aura Biosciences Preferred Dividends Chart

Aura Biosciences Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Preferred Dividends
Get a 7-Day Free Trial 10.94 0.00 0.00 0.00 0.00

Aura Biosciences Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Preferred Dividends Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
AURA
35GF Score
Aura Biosciences Inc AURA
Preferred Dividends is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Aura Biosciences Preferred Dividends Calculation

A dividend that is accrued and paid on a company's preferred shares.

Frequently Asked Questions Learn more about Preferred Dividends →
What does a Preferred Dividends of $0.00 Mil mean?
Aura Biosciences (AURA) has a Preferred Dividends of $0.00 Mil as of Jun. 2026. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Aura Biosciences and its competitors.
Is Aura Biosciences' Preferred Dividends too high?
Aura Biosciences' current Preferred Dividends is $0.00 Mil. Overall, Aura Biosciences has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Aura Biosciences' Preferred Dividends compare to FTH and ACRS?
Aura Biosciences' Preferred Dividends of $0.00 Mil can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Preferred Dividends for a Biotechnology company?
A good Preferred Dividends depends on the Biotechnology industry context. However, Preferred Dividends should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Preferred Dividends mean?
A high Preferred Dividends can signal that a stock is expensive relative to its fundamentals. Preferred Dividends is the total amount a company pays out as dividends on its preferred shares. View historical data on Aura Biosciences and its competitors. Aura Biosciences's current Preferred Dividends is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Aura Biosciences stock overvalued right now?
Aura Biosciences (AURA) has a current Preferred Dividends of $0.00 Mil. The current Preferred Dividends is $0.00 Mil. Aura Biosciences' overall GF Score™ is 35/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Preferred Dividends calculated?
Preferred Dividends is calculated from a company's financial statements. For Aura Biosciences (AURA), the current Preferred Dividends is $0.00 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Aura Biosciences Business Description

Address 80 Guest Street, Boston, MA, USA, 02135
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
35GF Score

Get the complete analysis for AURA

Preferred Dividends is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$7.81
Price